🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Intramuscular influenza vaccine

Found 646 matching trials

Entolimod on Immunosenescence in Healthy Geriatric Subjects Receiving Influenza Vaccination

PHASE2

Researchers are evaluating the safety and effectiveness of a single adminis...

Status

Completed

Location

Mayo Clinic in Rochester

Start Date

2019-10-30

Trial ID

NCT04176133

Treatments Being Tested

Entolimod Placebo Influenza vaccine

Immune Response of Intradermal and Intramuscular Preparations of Inactive Seasonal Influenza Vaccine in Older Age Group.

PHASE4

This is a prospective, Open label randomized study. A total of 220 adults a...

Status

Completed

Location

Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol University,

Start Date

2013-11

Trial ID

NCT02101749

Treatments Being Tested

trivalent inactivated influenza

Immunogenicity and Safety of Trivalent Influenza Vaccine in Non-pregnant HIV-infected Women

PHASE4

The overall aim of this project is to evaluate the immunogenicity of TIV va...

Status

Completed

Location

Nrf/Dst Vpd Rmpru

Start Date

2013-05

Trial ID

NCT01812980

Treatments Being Tested

Trivalent Inactivated Influenza Vaccine

Trial of Tolerability, Safety and Immunogenicity of the Flu-M Vaccine in Children Between 6 Months and 9 Years Old

PHASE3

Comparative trial of tolerability, reactogenicity, safety and immunogenicit...

Status

Completed

Location

LLC "Energiya zdorov'ya"

Start Date

2021-02-16

Trial ID

NCT05470582

Treatments Being Tested

Flu-M, Inactivated split influenza vaccine 0.5 mL Vaxigrip, Inactivated split influenza vaccine 0.5 mL Flu-M, Inactivated split influenza vaccine 0.25 mL Vaxigrip, Inactivated split influenza vaccine 0.25 mL

Study of Inactivated, Split-Virion Influenza Vaccine Compared With Standard Fluzone Vaccine in Infants and Children

PHASE2

Primary Objective: To evaluate for each influenza strain the non-inferiori...

Status

Completed

Location

Multiple Locations

Start Date

2006-10

Trial ID

NCT00391391

Treatments Being Tested

Split, Inactivated, Trivalent Influenza Vaccine Split, Inactivated, Trivalent Influenza Vaccine Split, Inactivated, Trivalent Influenza Vaccine ( Fluzone® 2006/2007 Formulation)Split, Inactivated, Trivalent Influenza Vaccine ( Fluzone® 2006/2007 Formulation)

Open-Label Study of H5 Vaccine in Participants of Protocol 04-077

PHASE1

This study may provide safety information on a flu vaccine given to childre...

Status

Completed

Location

UCLA Center For Vaccine Research

Start Date

2007-02

Trial ID

NCT00402649

Treatments Being Tested

Inactivated Influenza A/H5N1 Vaccine (sanofi pasteur)

Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Quadrivalent Influenza Virus Vaccine

PHASE4

The aim of this study is to evaluate the safety and immunogenicity of Fluzo...

Status

Completed

Location

Multiple Locations

Start Date

2013-09

Trial ID

NCT01946425

Treatments Being Tested

Fluzone® Quadrivalent Influenza Virus Vaccine, No Preservative Fluzone® Quadrivalent Influenza Virus Vaccine, No Preservative

Study of mRNA-1010 Seasonal Influenza Vaccine in Adults

PHASE3

This study includes 3 parts: Parts A, B, and C. The purpose of this study i...

Status

Completed

Location

Pinnacle Research Group

Start Date

2023-04-17

Trial ID

NCT05827978

Treatments Being Tested

mRNA-1010 Licensed Quadrivalent Inactivated Seasonal Influenza Vaccine

A Study of mRNA-1083 (SARS-CoV-2 and Influenza) Vaccine in Healthy Adult Participants, ≥50 Years of Age

PHASE3

The purpose of this study is to evaluate the immunogenicity, safety, and re...

Status

Completed

Location

Pinnacle Research Group-409 E 10th St

Start Date

2023-10-19

Trial ID

NCT06097273

Treatments Being Tested

mRNA-1083 Placebo Influenza Vaccine COVID-19 Vaccine

Comparison of Flu Vaccine Doses in Children

PHASE1

The purpose of this study is to evaluate the possibility that giving an inc...

Status

Completed

Location

Emory Children's Center - Pediatric Infectious Diseases

Start Date

2010-10

Trial ID

NCT01164553

Treatments Being Tested

Trivalent Inactivated Influenza Vaccine

Previous Next